Literature DB >> 23235103

Phacoemulsification and intraocular lens implantation after inadvertent intracapsular injection of intravitreal dexamethasone implant.

Jagat Ram1, Aniruddha Kishandutt Agarwal, Adit Gupta, Amod Gupta.   

Abstract

In this interventional case series, two eyes of two patients with diabetic macular oedema and one eye of a patient with complicated cataract secondary to uveitis associated with juvenile idiopathic arthritis had inadvertent injection of dexamethasone implant into the capsular bag. This was followed by successful completion of phacoemulsification and intraocular lens implantation. At 1-year follow-up, all patients maintained visual acuity of ≥ 20/40 with absence of macular oedema.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23235103      PMCID: PMC4544290          DOI: 10.1136/bcr-2012-007494

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Authors:  H Nida Sen; Lea T Drye; Debra A Goldstein; Theresa A Larson; Pauline T Merrill; Peter R Pavan; John D Sheppard; Alyce Burke; Sunil K Srivastava; Douglas A Jabs
Journal:  Ocul Immunol Inflamm       Date:  2012-04       Impact factor: 3.070

2.  Transconjunctival sutureless 23-gauge vitrectomy.

Authors:  Claus Eckardt
Journal:  Retina       Date:  2005 Feb-Mar       Impact factor: 4.256

3.  Effects of change in intraocular pressure on axial eye length and lens position.

Authors:  C Leydolt; O Findl; W Drexler
Journal:  Eye (Lond)       Date:  2007-01-19       Impact factor: 3.775

4.  Effect of ocular massage on intraocular pressure and corneal biomechanics.

Authors:  A K C Lam; D Chen
Journal:  Eye (Lond)       Date:  2007-07-06       Impact factor: 3.775

Review 5.  Intravitreal injection of therapeutic agents.

Authors:  Gholam A Peyman; Eleonora M Lad; Darius M Moshfeghi
Journal:  Retina       Date:  2009 Jul-Aug       Impact factor: 4.256

6.  Time course of changes in retinal thickness and visual acuity after intravitreal triamcinolone acetonide for diffuse diabetic macular edema with and without previous macular laser treatment.

Authors:  Fabio Patelli; Giuseppe Fasolino; Paolo Radice; Sabrina Russo; Giulio Zumbo; Filippo M DI Tizio; Giampiero Frisone; Stefano Marchi
Journal:  Retina       Date:  2005 Oct-Nov       Impact factor: 4.256

7.  Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.

Authors:  Careen Lowder; Rubens Belfort; Sue Lightman; C Stephen Foster; Michael R Robinson; Rhett M Schiffman; Xiao-Yan Li; Harry Cui; Scott M Whitcup
Journal:  Arch Ophthalmol       Date:  2011-01-10

8.  Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.

Authors:  Julia A Haller; Baruch D Kuppermann; Mark S Blumenkranz; George A Williams; David V Weinberg; Connie Chou; Scott M Whitcup
Journal:  Arch Ophthalmol       Date:  2010-03

9.  Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.

Authors:  Baruch D Kuppermann; Mark S Blumenkranz; Julia A Haller; George A Williams; David V Weinberg; Connie Chou; Scott M Whitcup
Journal:  Arch Ophthalmol       Date:  2007-03

10.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Authors:  Julia A Haller; Francesco Bandello; Rubens Belfort; Mark S Blumenkranz; Mark Gillies; Jeffrey Heier; Anat Loewenstein; Young-Hee Yoon; Marie-Louise Jacques; Jenny Jiao; Xiao-Yan Li; Scott M Whitcup
Journal:  Ophthalmology       Date:  2010-04-24       Impact factor: 12.079

View more
  1 in total

1.  Intralenticular Ozurdex® - One Year Later.

Authors:  Kathleen A Regan; Charles R Blake; Zachary L Lukowski; Siva S R Iyer
Journal:  Case Rep Ophthalmol       Date:  2017-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.